Skip to main content

Table 6 Relation between ESMO-MCBS score and real-world effectiveness

From: Oncologic orphan drugs approved in the EU – do clinical trial data correspond with real-world effectiveness?

 

Effectiveness

 

Survival benefit > 3 months

Survival benefit < 3 months, unknown magnitude or no benefit

Total

ESMO-score

Score A, B, 5 or 4

3

0

3

Score C, 1, 2 or 3

3

4

7

 

Total

6

4

10